Background: Men with low-risk prostate cancer are often offered active surveillance (AS), sparing them the toxicities of radical therapies and providing them with the opportunity to embark on healthy lifestyle and nutritional strategies. Annual magnetic resonance imaging (MRI) is increasingly being used to help monitor disease progress although its precise role has not been fully established. Hitherto no study has correlated changes in MRI disease status with Prostate Specific Antigen (PSA) dynamics among men managed with AS. Methods: We correlated 346 serum PSA levels with 346 MRIs of 138 men who had at least two prostate MRI scans, and who had prostate cancer managed with AS. All men were given lifestyle information guidance and 102 were also were also taking, long term, a polyphenol rich food supplement following initial recruitment in the UK’s Pomi-t study. Results: Men with progression seen on MRI had a mean 39.78% rise in PSA (confident interval (CI) 28 to 52%), compared to those whose disease shrunk (-16.05%, CI 14 to -46%), remained stable (1.62% CI -3 to 5%), or was not visualised (-1.62%, CI -14 to 11%) (ANOVA, P-value
|Journal||Journal of Lifestyle Diseases and Management|
|Publication status||Published - 2015|
Bibliographical noteThis article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.
- Active surveillance
- Multiparametric MRI
- Prostate cancer